Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd M&A Activity 2019

Jul 17, 2019

59255_rns_2019-07-17_0c7cce03-d812-48b3-8100-324da952f9f6.pdf

M&A Activity

Open in viewer

Opens in your device viewer

To, To,
BSE Limited, Listing Department,
25,P.J.Towers, National Stock ExchangeofIndia Ltd.,
Dalal Street, Exchange Plaza, Bandra Kurla Complex,
Mumbai - 400001 Bandra (East), Mumbai- 400051
Ref:Company Scrip Code: 532834 Ref:Symbol: CAMLINFINE11Series: EQ

Sr.No. Particulars Detailsofentities forming partofmerger
a) Detailsmbriefsuch as size, Nameofthe entity(ies): CFCL Mauritius
turnover etc. Pvt. Ltd., Mauritius being reverse merged
with its wholly owned subsidiary CFS
Europe S.p.A, Italy
Turnover asonMarch 31, 2019 Nil as incorporated to acquire 100% stake
CFS Europe S.p.A.
b) Whether the merger would fall Nota related party transaction
within
related
party
transaction( s) and whether the
promoter/ promoter group/ group
companies have any interest m
the entity being acquired?
c) Areaofbusinessofthe entity Specialty Chemicals
d) Rationale for merger To achieve more effective management
including optimum cash flow management,
enhancing administrative convenience and
costs and achieving a leaner corporate
structure
e) In caseofCash consideration - None, as the wholly owned subsidiaryof
amount
or
otherwise
share
the Company was reverse merged with the
exchange ratio step-down subsidiaryofthe Company.
f) Briefdetails
ofchange
m The Company was prior to merger holding
shareholding pattern(ifany) of 100% stake in CFS Europe S.p.A through
Listed Entity CFCL Mauritius Pvt. Ltd. Post-merger the
holding in CFS Europe S.p.A remams
unchanged.